Table 1.

Demographic and clinical characteristics of clinical study participants

	No CHD (n=77)	CHD (n=178)	ACS (n=70)
AGE (years)	62 ±1	65±0.6 (p=0.004)	64±1
BMI (Kg/m2)	28.2±0.5	27.5±0.3	27.8±0.5
% men	71	83	79
% diabetes	7.6	24.6 (p=0.01)	25.7 (p=0.03 vs. No CHD)
% hypertension	12.8	40.2 (p=0.015)	15.5 (p=0.04 vs. CHD)
% smokers	9.1	27.4 (p=0.039)	14
SBP	131±1	131±1	133±2
DBP	77±1	77±1	79±1
CREATININE	0.94±0.02	1.08±0.05 (p=0.02)	1.03±0.04 (p=0.04 vs. No CHD)
GLUCOSE	110±4	114±3	120±6
CHOLESTEROL	202±7	182±21 (p=0.016)	196±9
TRYGLYCERIDES	150±19	151±9	171±18
LDL	116±5	96±4 (p=0.019)	99±7 (p=0.02 vs. No CHD)
VLDL	35±4	33±2	40±3 (p=0.026 vs. CHD)
HDL	52±3	48±1	53±5
Creatine kinase	109±9	117±12	709±155 (p<0.001 vs. No CHD), (p<0.001 vs. CHD)
Pro-BNP	389±145	534±98	1330±509 (p=0.02 vs. No CHD), (p=0.03 vs. CHD)